An overview of the design and rationale for the phase 2 BRIDGET study looking at the addition of tucatinib to HER2-directed antibody therapy in breast cancer.
76 Electromagnetic Chip Bracketed vs Wire Bracketed Localization in Breast Conserving Surgery